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Ribosomal translation factors are fundamental for protein
synthesis and highly conserved in all kingdoms of life. The
essential eukaryotic elongation factor 1A (eEF1A) delivers ami-
noacyl tRNAs to the A-site of the translating 80S ribosome. Sev-
eral studies have revealed that eEF1A is posttranslationally
modified. Using MS analysis, site-directed mutagenesis, and
X-ray structural data analysis of Saccharomyces cerevisiae
eEF1A, we identified a posttranslational modification in which
the  amino group of mono-L-glutamine is covalently linked to
the side chain of glutamate 45 in eEF1A. The MS analysis sug-
gested that all eEF1Amolecules aremodified by this glutaminy-
lation and that this posttranslational modification occurs at all
stages of yeast growth. Themutational studies revealed that this
glutaminylation is not essential for the normal functions of
eEF1A in S. cerevisiae. However, eEF1Aglutaminylation slightly
reduced growth under antibiotic-induced translational stress
conditions. Moreover, we identified the same posttranslational
modification in eEF1A from Schizosaccharomyces pombe but not
in various other eukaryotic organisms tested despite strict conser-
vation of the Glu45 residue among these organisms. We therefore
conclude that eEF1A glutaminylation is a yeast-specific posttrans-
lationalmodification that appears to influence protein translation.
One of the most conserved biological processes is ribosomal
protein synthesis, comprising initiation, elongation, termina-
tion, and recycling steps. Each step is dependent on specific
translation factors. Eukaryotic elongation factor 1A (eEF1A),4 a
large GTPase that is one of the most abundant cytosolic pro-
teins, is important for the binding, stabilization, and delivery
of aminoacylated tRNA to the translating ribosome. Correct
codon–anticodon pairing of the aminoacyl–tRNA with the
mRNA at the ribosomal A-site triggers ribosome-dependent
hydrolysis of GTP and leads to dissociation of eEF1A from the
ribosome. eEF1A is reactivated by nucleotide exchange factor
eEF1B (1) and then able to reassociate with charged tRNA to
start a new translation cycle. Besides its essential role in mRNA
translation, eEF1Aparticipates inmany other cellular functions
and is reportedly involved in actin bundling, nuclear export (2),
signal transduction (3), apoptosis, proteasomal degradation,
and tumorigenesis (4, 5).
Crystal structures of archaeal, mammalian, and yeast eEF1A
(partially in complex with subunits of eEF1B) showed that the
elongation factor consists of three domains (I–III) (6–8).
Domain I is the GTP-binding domain and resembles GTPases
of the Ras family. Domains II and III are likely to act as a rigid
functional unit and are involved in aminoacyl–tRNA binding.
These domains were also reported to be implicated in the inter-
action with cytoskeletal proteins (9, 10).
eEF1A is extensively posttranslationally modified by lysyl
acetylation, methylation (11), ubiquitination, nitrosylation,
glutathionylation, phosphorylation (12), C-terminal methyl
esterification (13), and the attachment of ethanolamine phos-
phoglycerol (EPG) (14). Most posttranslational modifications
of eEF1A occur in domains II and III, whereas fewer modifica-
tions are found in the enzymatic GTPase domain. However,
domain I of eEF1A is posttranslationallymodified by Legionella
pneumophila glucosyltransferases Lgt1–3, which attach glu-
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cose onto Ser53 of yeast and mammalian eEF1A (15, 16).
Although toxin-induced modification of eEF1A results in inhi-
bition of protein synthesis in yeast and mammalian cells, the
roles and functional consequences of most endogenous post-
translational modification of eEF1A are still not clear (17).
eEF1A belongs to the most conserved proteins across all
kingdoms of life (18). However, in contrast to the prokaryotic
orthologue, eukaryotic and archaeal EF1A contain an addi-
tional subdomain, the helix A*–loop–helix A region (amino
acids 36–69). This double helix insert is part of the switch I
region within the GTPase domain. Extensive structural altera-
tions of this region during GDP/GTP exchange and during
interactionwith the ribosome suggest a pivotal role of this addi-
tional helix–loop–helix region in eukaryotic organisms (7).
Here we describe, for the first time, a novel type of posttransla-
tional modification, the glutaminylation of a glutamate residue,
that occurs within the helix A*–loop–helix A region of yeast
eEF1A. We show that the glutamine residue is attached via its 
amino group to the side chain carboxyl group of Glu45 within
eEF1A.Glutaminylation of eEF1Awas detected in Saccharomyces
cerevisiae and Schizosaccharomyces pombe. Experiments with
S. cerevisiae expressing Glu45 eEF1Amutants instead of the wild-
type elongation factor indicate that glutaminylation slightly
enhances growth defects under translational stress conditions.
Results
Posttranslational modification of the switch I region in eEF1A
We set out to specifically analyze the helix A*–loop–helix
A region in EF1A for unconventional posttranslational
modifications. eEF1A was purified from S. cerevisiae using
affinity chromatography with His6-tagged guanine nu-
cleotide exchange factor eEF1B (19). MS analysis revealed
that the tryptic peptide 42-FEKEAAELGK-51 [M2H]2 
625.3251 was shifted to a higher mass by 128.05858 Da  2
ppm (Fig. 1A). The additional mass suggested a modification
with an organic molecule with the sum formula C5H8N2O2,
which is exactly the mass of the amino acid glutamine
reduced by an H2Omolecule. Further CIDMS-MS fragmenta-
tion analysis showed that the additional mass was clearly
attached to the side chain of Glu45(Fig. 1B). The attachment of
a single glutamine to proteins has so far not been reported.
We termed this novel type of posttranslational modification
“glutaminylation.”
Confirmation of eEF1A glutaminylation at Glu45 by
site-directed mutagenesis
To confirm the glutaminylation of Glu45 in eEF1A, we per-
formed MS-MS analysis with the site-directed mutants eEF1A
E45A and eEF1AE45D expressed in and isolated from S. cerevi-
siae (Fig. 2). Mutation of Glu45 to alanine prevented modifica-
tion by glutamine. Similarly, the mutant eEF1A E45D with
shortened side-chain carbonyl was not modified. Thus, glu-
taminylation seems to be highly specific for glutamate at posi-
tion 45. Notably, using wild-type eEF1A, we were not able to
identify unmodified eEF1A in yeast cells. Also, at different cell
stages of yeast growth, eEF1A was always completely glutami-
nylated (supplemental Fig. 1).
Figure 1. eEF1A isolated from S. cerevisiae is posttranslationally modified in the GTPase domain at Glu45. A, extracted ion chromatogram showing that the
tryptic peptide 42-FEKEAAELGK-51 ([M2H]2625.3251) of yeast EF1A is covalentlymodifiedby the attachmentof amass of 128.059Da. B,MS-MS fragmentation
analysis revealed that the tryptic peptide 42-FEKEAAELGK-51 of yeast EF1A is modified at a side chain of Glu45. Immon., immonium ion; Seq., sequence.
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L-Glutamine is linked to Glu45 via the amino group
To analyze glutaminylation in molecular detail and clarify
how the glutaminyl moiety is attached, we used the 1.67-Å-
resolution crystal structure of S. cerevisiae eEF1A in complex
with the C-terminal catalytic domain of the exchange factor
eEF1B (PDB code 1F60 (8)), which is the highest-resolution
structure available for this protein in the Protein Data Bank. An
unassigned electron density close to residue Glu45 permitted
addition of a glutaminyl moiety in a defined orientation (Fig. 3,
A and B). The  amino group of the glutamine is covalently
linked to the  C atom of the carboxylic group of the Glu45 side
chain. This is a peptide bond–like connection with a character-
istic planar geometry and a short C-N bond. The bond forma-
tion results in the loss of one oxygen atom of the carboxylic
group fromGlu45 and equates to the release of awatermolecule
(Fig. 3C). The modification extends the glutamate side chain as
a branchedmoiety, with the side chain and the carboxylic group
of glutamine both exposed to the surface of theGTPase domain
of eEF1A. Structure refinement comparing the fit of L- and
D-glutamine enantiomers clearly indicated the attachment of
L-glutamine. Multiple posttranslational modifications were
described previously for eEF1A (11–14). Of those, monometh-
ylation of Lys30 and trimethylation of Lys79 (11) could also be
assigned to electron density features, and these modifications
were included in the final refined structure (PDB code 5O8W)
(supplemental Fig. 2, A and B). The attachment of a glutamate-
derived glutamyl is a mechanism known for several proteins,
e.g. in polyglutamylation of  and  tubulin (20), -glutamyla-
tion in glutathione metabolism, or xenobiotics detoxification
(21). In contrast, the attachment of a single glutamine via its 
amino group has not been reported previously.
Mouse, bovine, fish, insect, and archaeal eEF1A are not
glutaminylated at Glu45
Glu45 is highly conserved within the helix A*–loop–helix A
region of eukaryotic eEF1A and also present in several archaeal
EF1A molecules (Fig. 4). To determine whether glutaminyla-
tion of Glu45 is also conserved, we isolated elongation factors
from fission yeast (S. pombe), archaea (Haloferax volcanii),
zebrafish (Danio rerio) ZF4 fibroblasts, bovine (Bos taurus)
liver, mouse (Mus musculus) brain and liver, and wax moth
larvae (Galleria mellonella) homogenate and analyzed the pro-
teins by LC/MS-MS. Identified peptidic fragments were well-
assigned and clearly indicated that glutaminylation atGlu45was
present in eEF1A from fission yeast (S. pombe) but not present
in elongation factors isolated from any of the other organisms
(Fig. 5 and data not shown). In addition, we analyzed the crystal
structures of eEF1A from rabbit (PDB code 4C0S (7), Aeropy-
rum pernix (PDB codes 3WXM (22) and 3VMF (23)), and Sul-
folobus acidocaldarius (PDB codes 1SKQ (24) and 1JNY (6)). In
Figure 2. Confirmation of eEF1A modification by site-directed mutagenesis of Glu45 in S. cerevisiae. A, MS-MS fragmentation analysis by collision-
induced dissociation (CID) of the eEF1A E45D mutant expressed and purified from S. cerevisiae genetically deprived of wild-type eEF1A. A representative
MS-MS fragmentation pattern (left panel) and extracted ion chromatogram (right panel) are shown. Posttranslational modification of the tryptic peptide
42-FEKDAAELGK-51 of eEF1A was not observed. B, electron transfer dissociation (ETD) MS-MS analysis of the eEF1A E45A mutant expressed and purified from
S. cerevisiae genetically deprived of wild-type eEF1A. Posttranslational modification of the chymotryptic peptide 43-EKAAAELGKGSFKY-56 was not observed.
A representative MS-MS fragmentation pattern (left panel) and extracted ion chromatogram (right panel) are shown.
Figure 3. Crystal structure of glutaminylated yeast eEF1A. A, the crystal structure of posttranslationally modified eEF1A from the eEF1A–eEF1B complex.
The helix A*–loop–helix A region of the GTPase domain (brown) of eEF1A is marked. The modified Glu45 is shown as sticks and balls. Domain II and domain III
are shown in cyan and green, respectively. eEF1B was omitted for clarity. Original structure factors were deduced from Ref. 8. B, electron density map 2mFo–dFc
(gray), contoured at a level of 1.7  in the vicinity of the L-glutaminyl moiety (yellow) covalently attached via its  amino group to Glu45 of yeast eEF1A. C,
chemical structure of the covalent linkage of the glutaminyl moiety (red) to Glu45.
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agreement with our MS data, unassigned electron density
around Glu45 or equivalent residues was not detectable in any
of the three structures containing mammalian or archaeal
eEF1A. Thus, glutaminylation of eEF1A seems to be restricted
to yeast.
Glutaminylation of eEF1A increases yeast growth defects
under translational stress conditions
To analyze the biological effects of Glu45 glutaminylation of
eEF1A, we performed growth assays under various cell stress
conditions with S. cerevisiae strains in which wild-type eEF1A
was substituted by eEF1A-E45A, -E45D, or -E45K (supplemen-
tal Fig. 3A). Yeast cells expressing themutant versions of eEF1A
were viable anddid not display growth defects under a variety of
stress conditions, including temperature stress, osmotic stress,
or endoplasmic reticulum stress in the presence of benomyl,
caffeine, or polymyxin (supplemental Fig. 3B).
Interestingly, the response of the tested eEF1A mutants
toward translation-specific stress conditions induced by the
antibiotics Geneticin, paromomycin, and, to a lesser extent,
anisomycin showed that modification at Glu45 by glutaminyla-
tion (eEF1AGlu45-glut) slightly enhanced growth defects com-
pared with mutant eEF1A E45D that was not modified by
attachment of glutamine (Fig. 6). Moreover, introduction of a
local positive charge and bulky side chain, as in the E45K
mutant, increased the susceptibility of the mutant yeast strain
toward translation-specific antibiotics. These data suggest that
glutaminylation of eEF1A at the critical position Glu45 might
regulate translation under specific growth conditions.
Glycosylation of Ser53 of eEF1A by the Legionella effector Lgt3
is not influenced by glutaminylation
The results of the previous experiments with translational
inhibitors suggested that site-directed mutation (eEF1A E45K)
or glutaminylation of Glu45might alter the conformation of the
helix A* loop region of the switch I region of eEF1A. Glu45 is
structurally located close to Ser53, the specific modification site
of the L. pneumophila toxin effector glucosyltransferases Lgt1,
2, and 3 (15, 16). To analyze whether glutaminylation of Glu45
results in structural alterations of the helix A*–loop–helix A
region unfavorable for Lgt3-catalyzed glucosylation, we com-
pared the initial velocities of glycosylation of non-glutaminy-
lated (eEF1A purified from mouse liver) versus glutaminylated
eEF1A (purified from S. cerevisiae) (supplemental Fig. 4). Addi-
tionally, we compared the glucosylation of the ternary complex
(eEF1A, GTP, and Phe-tRNAPhe) constituting the bona fide
substrate of Lgt3.We found that the initial glucosylation rate of
glutaminylated and non-glutaminylated eEF1A within the ter-
nary complex was similar, showing that Glu45 glutaminylation
does not influencemodification of the elongation factor at Ser53
by Lgt3.
Discussion
Here we show, by using tandemmass spectrometric analysis,
site-directedmutagenesis, and structural data that eEF1A from
yeast is modified by the attachment of a single glutamine moi-
ety to amino acid Glu45 within the GTPase domain. Structural
data reveal covalent linkage of L-glutamine via the  amino
group.
Although glutamylation and polyglutamylation (the attach-
ment of glutamic acids) are well-known posttranslational mod-
ifications (e.g.modification of - and -tubulin (20)) catalyzed
by -glutamyltransferase (21), the posttranslational modifica-
tion of proteins by attachment of glutamine (glutaminylation)
via the  amino group has not been reported previously.
The chemical principle of the novel posttranslational modi-
fication reaction reported here appears to be similar to the reac-
tion catalyzed by glutaminyl-tRNA synthetase (Gln-RS) during
the charging of tRNA at the 3 acceptor stem region, which
results in the same covalent linkage of a glutaminyl moiety (25).
Several aminoacyl-tRNA synthetase (aa-RS) paralogs with
unknown functions exist in various species, including yeast.
The class II lysyl-tRNA synthetase paralog GenX/PoxA/YjeA
was shown to attach a lysine residue to another lysine of Esch-
erichia coli elongation factor P (26, 27). This lysinemodification
resembles the glutaminylation reaction of eEF1A. Thus, one
may speculate that glutaminylation of eEF1Amight also be cat-
alyzed by a glutaminyl-tRNA synthetase paralog. Notably, the
Figure 4. Glu45 in translation elongation factor 1A is highly conserved from archaea to human. Shown is the amino acid sequence alignment of the N
terminus of eEF1A of various organisms. The alignment was prepared with ClustalW with eEF1A from S. cerevisiae (accession no. P02994), S. pombe (accession
no. P0CT53), M. musculus (accessionno. P10126), B. taurus (accessionno. P68103), G. mellonella (accessionno.Q8MWN6), D. rerio (accessionno.Q92005), Homo
sapiens (accession no. P68104), and H. volcanii (accession no. D4GWR0). Secondary structural elements were deduced from S. cerevisiae eEF1A (PDB code 1IJF).
The N-terminal part of the switch I region, which is missing in prokaryotic EF-Tu, is highlighted.
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site of glutaminylation in eEF1A is located close to the 3 ami-
noacyl acceptor stem of the eEF1A-bound aa-tRNA (supple-
mental Fig. 5).
So far, it is unclear whether glutaminylation in yeast is a tran-
sient and reversible modification. Despite extensive efforts, we
were not able to identify unmodified eEF1A in yeast cells. Anal-
Figure 5. Mouseelongation factor 1A isnotglutaminylatedatGlu45.A, SDS-PAGEof eEF1Aaffinity-purified frommouse liver (mEF1A),whichwasused formass
spectrometric analysis. B, CID MS-MS revealed no modification of Glu45 in the chymotryptic peptide 43-EKEFAAEMGKGSF-54 (precursor m/z 642.3 (2)). Immon.,
immonium ion; Seq., sequence. C, a representative LC/MS-MS extracted ion chromatogram of the peptide 43-EKEAAEMGKGSF-54 peak at m/z 642.3 (2) from
mouse eEF1A.
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yses performed at different cell stages of yeast growth exclu-
sively resulted in detection of completely glutaminylated
eEF1A (supplemental Fig. 1). By contrast, we were not able to
detect glutaminylation of mammalian, fish, or insect eEF1A.
The site of glutaminylation and the nature of the acceptor
amino acid is highly specific. We observed that amino acid
point mutations of the glutaminyl attachment site (Glu45) of
yeast eEF1A prevented glutaminylation, even when gluta-
mate was replaced by negatively charged aspartic acid with a
C1 atom-shortened side chain. This demonstrates that the
attachment of glutamine is strictly specific for Glu45.
Besides glutaminylation of eEF1A, there are three other
“unusual” posttranslationalmodifications also found in eukary-
otic ribosome-associated factors (28): EPG modification of
Glu301 and Glu374 in eEF1A, hypusine modification of eukary-
otic initiation factor 5A (eIF5A), and diphthamidemodification
of eukaryotic elongation factor 2 (eEF2) (29). The precise func-
tional roles of these modifications are not well-understood.
Although the diphthamide modification might play a role in
translation fidelity (30), the function of hypusine andEPGmod-
ifications are still enigmatic (28). Expression of a glutaminyl-
deficientmutant of eEF1A (E45A or E45D) in S. cerevisiae, after
deletion of endogenous eEF1A, demonstrated that attachment
of glutamine to eEF1A is not essential for growth. Surprisingly,
translation stress conditions induced byGeneticin, paromomy-
cin, or anisomycin showed growth retardation of native glu-
taminylated eEF1A (local neutral charge) or eEF1A with an
introduced bulkier side chain of lysine at position Glu45 (local
positive charge) in comparison with the E45D mutant (local
negative charge). Thus, in the eEF1A E45K mutant, as in the
Glu45-glutaminylated eEF1A, the effect of the bulky and pos-
itively charged side chain might influence the interaction
with the ribosomal factor-binding site and, therefore, trans-
lation efficiency. These data suggest that, in yeast, glutami-
nylation might have a regulatory function in protein synthe-
sis. Previously, we reported that Ser53 of eEF1A is modified
by glucosylation catalyzed by the L. pneumophila effectors
Lgt1–3 (15, 16). We found that Lgt-induced glucosylation
did not differ with glutaminylated and non-glutaminylated
eEF1A, which is a further indication that modification of
Glu45 did not cause drastic structural changes of the
molecule.
Recently, themammalian elongation complex structure with
eEF1A bound to the 80S ribosome has been reported (31). In
this complex, the conserved Glu45 is oriented close to the
sarcin–ricin loop. The sarcin–ricin loop is suggested to stimu-
late the GTPase activity of eEF1A after codon–anticodon rec-
ognition at the A-site of the ribosome (31, 32). Analysis of the
described mammalian 80S ribosome complex reveals that glu-
taminylation of amino acid Glu45 of eEF1A would be accom-
modated in this complex. On the other hand, it is conceivable
that the glutaminylation is involved in binding of the eEF1A
ternary complex to the factor-binding site of the ribosome and,
therefore, has the potential to influence translation (supple-
mental Fig. 5).
Taken together, here we describe a novel posttranslational
modification of yeast eEF1A by glutaminylation. In all organ-
isms, the genomic content is restricted to a specific protein
repertoire. Fine-tuning of protein functions (e.g. in signaling
events) and/or functional extensions are achieved by a large
array of posttranslational modifications, resulting in additional
diversification of the proteome. Translation elongation factors
especially appear to be substrates of an extended spectrum of
posttranslational modifications not observed in other proteins.
Our findings add another type of posttranslational modifica-
tion to this spectrum. It remains to be clarified whether glu-
taminylation is restricted to eEF1A or also observed in other
proteins. Identification of the responsible enzyme will be an
essential requirement for future detailed characterization of
this novel posttranslational modification.
Experimental procedures
Strains, vectors, and materials
E. coli DH10B and TG1 were used for cloning and E. coli
BL21 (DE3) for recombinant protein production (Invitrogen).
Haploid S. cerevisiaeMH272–3f (ura3, leu2, his3, trp1, ade2)
or diploidMH272–3f/a (ura3/ura3, leu2/leu2, his3/his3, trp1/
trp1, ade2/ade2) was used for yeast genetic studies (33). The
following commercial E. coli and S. cerevisiae/E. coli shuttle
vectors were used: pET28a, pET11 (Novagen, Madison, WI),
and pRS313[His3] (34). For yeast transformation, standard
genetic techniques were applied (35). All sequences of the cor-
responding plasmids and site-directed mutations were con-
firmed by sequencing (GATC Inc., Konstanz, Germany). DNA-
modifying enzymes, Pfu DNA polymerase, 5-fluoroorotic acid,
and kits for plasmid DNA and PCR product isolation were pur-
chased from Fermentas (St. Leon-Rot, Germany). UDP-[14C]g-
lucose was from American Radiolabeled Chemicals (St. Louis,
MO). The components of liquid medium for S. cerevisiae and
E. coli were from Difco (BD Biosciences) and Carl Roth GmbH
(Karlsruhe, Germany), respectively. S. cerevisiae was cultivated
in YPD (1% yeast extract, 2% peptone, and 2% glucose) or min-
imal (0.67% yeast nitrogen base without amino acids and with
ammonium sulfate, 2% glucose or 2% galactose, and the corre-
sponding supplement) medium at 30 °C. S. pombe was culti-
vated in YES medium (0.5% yeast extract, 3% glucose, and
0.02% (of each) adenine, leucine, histidine, and uracil). Glu-
cose, galactose, uracil, adenine, histidine, tryptophan, lysine,
and leucine were from Sigma. The yeast DNA isolation kit
was from Pierce (Thermo Fisher Scientific, Bonn, Germany).
Isopropyl--D-thiogalactopyranoside was from Roth. RNase
inhibitor was from Promega (Mannheim, Germany). All
other reagents were of analytical grade and purchased from
commercial sources.
Figure6.Glutaminylationormutationof eEF1AGlu45 to lysine increased
growthdefectunder translational stress conditions inyeast.Growthphe-
notypes of S. cerevisiae strains expressing wild-type eEF1A Glu45-glut, eEF1A
E45D, or eEF1A E45K. Serial dilutions of the corresponding S. cerevisiae vari-
ants were spotted onto YPGal (2% galactose) or YPD agar supplemented with
different stress agents (50 ng/ml Geneticin, 350 g/ml paromomycin (Paro),
or 5 g/ml anisomycin (Aniso)) and cultivated for 72 h at 30 °C.
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Protein purification
The cloning, recombinant expression and purification of
Lgt3 (gene lgt3/lpg1488) from L. pneumophila strain Philadel-
phia-1 was described previously (36). For recombinant eEF1B
(37) and Lgt3 protein production, the corresponding genes
were induced with 0.2 mM isopropyl--D-thiogalactopyra-
noside at 22 °C overnight on a shaker. Bacterial cells were
collected by centrifugation and lysed by French press on ice.
The proteins were purified by nickel affinity chromatogra-
phy using HisTrap columns (GE Healthcare) connected to
an ÄKTA purifier (GE Healthcare) and stored in 10% glycer-
ol/TBS solution at80 °C. Purification of native EF1A from
S. cerevisiae, S. pombe, H. volcanii, zebrafish ZF4 cells,
bovine liver tissue, mouse brain or liver, or total G. mello-
nella homogenate was performed by a method based on
eEF1A interaction with His-tagged eEF1B as described pre-
viously (37).
Cloning and mutagenesis of S. cerevisiae eEF1A
The coding sequence of yeast eEF1Awith500-nt upstream
and downstream regions was amplified from S. cerevisiae chro-
mosomal DNA using primers 5-CATATCACATAGGATC-
CAACAGGCG and 5-CATTACAGATAGCGTCGAC-
CAAAGTATT (engineered restriction endonuclease sites are
underlined). The PCR product was digested with BamHI/SalI
restriction endonucleases and ligated into similarly digested
pRS313. Site-directedmutagenesis was performed as described
previously using the QuikChange (Stratagene) technology with
the oligonucleotides 5-GTTCGAAAAGGATGCCGCT-
GAATTAG/5-CTAATTCAGCGGCATCCTTTTCGAAC, 5-
GTTCGAAAAGAAAGCCGCTGAATTAG/5-CTAATT-
CAGCGGCTTTCTTTTCGAAC and 5-GTTCGAAA-
AGGCAGCCGCTGAATTAG/5-CTAATTCAGCGGCTG-
CCTTTTCGAAC to generate eEF1Awith the E45D, E45K, and
E45A substitutions, respectively.
Engineering of S. cerevisiae strains with eEF1A mutations
Construction of S. cerevisiae variant with inactivated chro-
mosomal copies of eEF1A and containing wild-type eEF1A on
an Ura3 marker–containing plasmid was described previously
(38). This strainwas transformed individually with the pRS313-
based plasmids coding for eEF1A wild-type, E45D, E45K, and
E45A and passed over 5-fluoroorotic acid–containing agar
plates (39) to remove the initial Ura3marker–carrying plasmid
coding for wild-type eEF1A.
Yeast growth assay
To estimate yeast growth phenotypes, engineered S. cerevi-
siae cells were titrated 10-fold from the starting value ofA600
1.0. From each dilution, an aliquot of 5 l of suspension was
dropped onto SD agar supplemented with the corresponding
marker substances. Where indicated, additional stress
agents were included (20 mM DTT, 2% galactose, 50 ng/ml
Geneticin, 350 g/ml paromomycin, 5 g/ml anisomycin, 1
M sorbitol, 1 M NaCl, 1 M KCl, 10 g/ml benomyl, 0.15%
caffeine, or 200 g/ml polymyxin), or the pH level was
adjusted correspondingly. Petri plates were incubated for
3–5 days at 30 °C (or at the temperature mentioned in the
figure legends) before photography. In comparison with liq-
uid culture experiments, assays on solid medium led to
results that were more conclusive.
Glucosyltransferase assay
Glucosylation was performed with 140 nM recombinant His-
tagged Lgt3 and eEF1Aor the eEF1A-GTP-Phe-aatRNAPhe ter-
nary complex (3 M) in a total volume of 20 l. Production of
Phe-tRNAPhe and ternary eEF1A complex formation was per-
formed as described previously (36). The standard glycosylation
reaction was performed at 30 °C for the indicated times in 20 mM
Tris-HCl (pH 7.5), 150 mMNaCl, 1 mMMnCl2, and 10 MUDP-
[14C]glucose.The reactionwas stoppedby additionof SDS sample
buffer and heating at 95 °C for 5 min. Subsequently, the samples
were subjected to polyacrylamide gel electrophoresis (40).
Proteins were stained with Coomassie Brilliant Blue R250,
and radiolabeled bands were analyzed by phosphorimaging
and quantified using ImageQuant 5.2 (GE Healthcare) and
Sigma Plot.
LC/MS-MS analysis
For in-gel digestion, the excised gel bands were destained
with 30% acetonitrile, shrunk with 100% acetonitrile, and dried
in a vacuum concentrator (Concentrator 5301, Eppendorf,
Hamburg, Germany). Digests with trypsin were performed at
37 °C and digests with chymotrypsin at 25 °C overnight in 0.1
M NH4HCO3 (pH 8). About 0.1g of protease was used for one
gel band. Peptides were extracted from the gel slices with 5%
formic acid. LC/MS-MS analyses were performed on a Q-TOF
(quadrupole time-of-flight) mass spectrometer (Agilent 6520,
Agilent Technologies) and on an ion trap mass spectrometer
(Agilent 6340, Agilent Technologies) equipped with an ETD
source. Both instruments were coupled to a 1200 Agilent nano-
flow system via aHPLC chip cube electrospray ionization inter-
face. Peptides were separated on anHPLC chip with an analyt-
ical column of 75-m inner diameter and 150-mm length and
a 40-nl trap column, both packed with Zorbax 300SB C-18
(5-m particle size). Peptides were eluted with a linear acetoni-
trile gradient with 1%/min at a flow rate of 300 nl/min (starting
with 3% acetonitrile). The Q-TOF was operated in the 2-GHz
extended dynamic rangemode.MS-MS analyses were performed
usingdata-dependent acquisitionmode.After anMSscan (2 spec-
tra/s), a maximum of three peptides were selected for MS-MS (2
spectra/s). Singly charged precursor ions were excluded from
selection. Internal calibration was applied. The ETD ion trap was
operated in data-dependent acquisition mode. After an MS scan
(standard enhanced mode), a maximum of three peptides were
selected forMS-MS (standard enhancedmode). The ICC control
for the survey scanwas set to 350,000, and themaximumaccumu-
lation timewas set to 300ms. The accumulation time for fluoran-
thene was set to 4 ms (according to an ICC of 500,000–600,000),
and the ETD reaction was set to 100 ms. Resonance excitation
(smart decomposition) was used for doubly charged peptides.
Mascot Distiller 2.3 was used for raw data processing and for gen-
erating peak lists, essentially with standard settings for theAgilent
Q-TOF or Agilent ion trap, respectively. Mascot Server 2.3 was
used fordatabasesearchingwith the followingparameters:peptide
y y
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mass tolerance, 20 ppm (Q-TOF)/1.1 Da (ion trap); MS-MSmass
tolerance, 0.05Da (Q-TOF)/0.3Da (ion trap); enzyme, “trypsin”or
“chymotrypsin”with twouncleaved sites allowed; variablemodifi-
cations, carbamidomethyl (C), Gln- pyroGlu (N-term. Q), oxi-
dation (M), and hexose (ST). For protein identification, a custom
database was used.
X-ray structure analysis and refinement
The vicinity of Glu45 in the 1.67-Å-resolution X-ray struc-
ture of eEF1A from S. cerevisiae (PDB code 1F60 (8)) was
inspected for unassigned electron density, whichwas calculated
using TLS (translation, libration, screw motion) refinement in
phenix.refine (41) with coordinates and structure factors
retrieved from the Protein Data Bank. ThemFo–dFc difference
electron density map clearly indicated the position and orien-
tation of the posttranslational modification. Water molecules
in the proximity of Glu45 were removed, and the glutaminyla-
tion wasmanually inserted as covalent attachment to Glu45 in a
peptide bond–like manner between the  amino group of glu-
tamine and the  C atom of the Glu45 side chain. The structure
was refined employing restraints for a peptide-like bond
according to Ref. 42. Specifically, refinement targets for atomic
distances were set to 1.336 Å (NGln-CE45), 1.229 Å (CE45-
OE45), 1.459 Å (CGln-NGln), and 1.525 Å (CE45-CE45).
Refinement targets for the angles were set as follows: 121.7°
(CGln-NGln-CE45), 122.7° (NGln-CE45-OE45), 120.1° (OE45-
CE45), and 117.2° (NGln-CE45-CE45). In addition, planarity
restraints were used for atoms CGln, NGln, CE45, CE45, and
OE45. After refinement, these distances and the plane were
identical to the ideal values. The quality of the model and fit
to the electron density were compared for L- and D-gluta-
mine, and the ideally fitting L-enantiomer was included
in the final structure. Water molecules were inserted, and
model buildingwas completed usingCOOT (43). This included
insertion of three polyethylene glycol moieties and two addi-
tional posttranslationalmodifications anN-monomethylation
of Lys30 and N,N,N-trimethylation of Lys79. Electron den-
sitywas visible for an additional short-helical peptide thatwas
likely to be part of the C terminus of eEF1A, as fragmentary
electron density at 1 and continuous electron density at 0.5
connected that peptide to the C terminus of eEF1A. However,
the connecting loop was not ordered enough to allow refine-
ment. The structure was refined using phenix.refine with TLS
to a crystallographic R and Rfree of 15.6% and 18.4%, respec-
tively. The quality of the structure was checked using MolPro-
bity (44). There was no Ramachandran outlier, and 97.44% of
the residues were in the favored regions. Data refinement sta-
tistics are summarized in supplemental Table 1. The figures
were prepared using the PyMOL molecular graphics system
(version 1.5.0.4, Schrödinger, LLC).
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Table S1: Refinement statistics of the eEF1A-eEF1BĮ complex. 
Resolution (Å) 20.0 – 1.67 
Reflections  
Refinement 63528 
Test set 3217 
Number of atoms  
Protein (including PTM) 4271 
Water 725 
Ligands 30 
R / Rfree 15.58 / 18.44 
R.m.s deviations  
Bonds (Å) 0.009 
Angles (°) 0.97 
Ramachandran plot (%)  
Favored 97.44 
Allowed 2.56 
Disallowed 0.00 
Note: Data were collected and processed by Andersen et al. (1) and Pedersen et al. (2).
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Glutaminylation of yeast eEF1A 
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Suppl. Fig. 1. Glutaminylation of yeast eEF1A is not depending on a specific growth phase. Extracted 
ion chromatogram of the chymotryptic peptide 43-EKEAAELGKGSFKY-56 of eEF1A (precursor m/z = 
421.97 (4+)) isolated from S. cerevisiae grown in logarithmic (A) or stationary phase (B). The MS/MS data 
revealed quantitative modification of E45. The unmodified peptide could not be detected. Collision-induced 
dissociation MS/MS analysis of the tryptic peptide 42-FEKEAAELGK-51 of yeast eEF1A (precursor m/z 
= 642.3 (2+)) in logarithmic (C) or stationary growth phase (D) is shown.
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Suppl. Fig. 2. Mono- and trimethylation sites in the eEF1A structure (PDB 5O8W). Nİ-
monomethylated K30 (A) and Nİ,Nİ,Nİ-trimethylated K79 (B) of the eEF1A structure are shown in stick-
and-ball presentation with surrounding 2mFo-dFc electron density map (grey) contoured at a level of 1.0 ı.
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Suppl. Fig. 3. S. cerevisiae expressing eEF1A E45 mutants were not influenced by various stress 
conditions. (A) Amount of engineered eEF1A in different variants of S. cerevisiae. Yeast were grown in 
YPD broth to an OD600 = 0.5, lyzed and tested in Western blotting with anti-eEF1A serum and with the sera 
against ribosomal proteins Rps9/Rpl24 as loading control. Please note that the concentration of eEF1A 
E45A is slightly reduced probably due to its instability or lower production. (B) Growth phenotypes of 
S. cerevisiae strains containing eEF1A with E45 substitutions. Serial dilutions of the corresponding yeast 
variants were spotted onto YPD agar supplemented with different stress agents (1 M sorbitol, 1 M NaCl, 
1 M KCl, 10 g/ml benomyl, 0.15% caffeine, 200 g/ml polymyxin, 20 mM DTT, or pH 8) and cultivated 
for 72 h at 30°C or 15°C.  
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Suppl. Fig. 4. Glucosylation of S53 of eEF1A in the ternary complex is not affected by glutaminylation. 
Kinetics of 14C-glucosylation of non-glutaminylated eEF1A (A) and glutaminylated eEF1A (B) by 
Legionella glucosyltransferase Lgt3 in the absence (open circles) or presence of Phe-tRNAPhe and GTP 
(filled circles). The amount of eEF1A glucosylation is shown as the mean (+/- SD) of at least three 
independent experiments. 
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Suppl. Fig. 5. Location of E45 in rabbit eEF1A bound to the eukaryotic ribosome. Cryo-electron 
microscopy structure of the (80S) mammalian elongation complex comprising the large (60S, violet) and 
the small (40S, yellow) ribosomal subunits (PDB 5LZS) (3). tRNAs at the P and E site are shown in grey, 
mRNA is shown in dark red. Insert: The structure of eEF1A at the A-site of the ribosome is shown with E45 
(red, stick-and-ball representation) located between the tRNA (orange) and the ribosomal L23 protein 
(blue). The sarcin-ricin loop is shown in violet.  
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